{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:36:32Z","timestamp":1760852192655},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T00:00:00Z","timestamp":1123718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s00280-005-0011-x","type":"journal-article","created":{"date-parts":[[2005,8,10]],"date-time":"2005-08-10T13:44:17Z","timestamp":1123681457000},"page":"120-124","source":"Crossref","is-referenced-by-count":11,"title":["Role of plasma lipids and lipoproteins in predicting amphotericin B-induced nephrotoxicity in pediatric oncology patients"],"prefix":"10.1007","volume":"57","author":[{"given":"Kishor M.","family":"Wasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Traci","family":"Corr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,8,11]]},"reference":[{"key":"11_CR1","first-page":"781","volume":"151","author":"DA Rothon","year":"1994","unstructured":"Rothon DA, Mathias RG, Schechter MT (1994) Prevalence of HIV infection in provincial prisons in British Columbia. Can Med Assoc J 151:781\u2013787","journal-title":"Can Med Assoc J"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/clinids\/14.Supplement_1.S154","volume":"14","author":"RD Meyer","year":"1992","unstructured":"Meyer RD (1992) Current role of therapy with amphotericin B. Clin Infect Dis 14:S154\u2013S168","journal-title":"Clin Infect Dis"},{"key":"11_CR3","first-page":"251","volume-title":"Manual of medical therapeutics","author":"WC Dunagan","year":"1989","unstructured":"Dunagan WC, Powderly WG (1989) Antimicrobials and Infectious Diseases. In: Dunagan WC, Ridner ML (eds) Manual of medical therapeutics. Little, Brown and Company, Boston, pp 251\u2013252"},{"key":"11_CR4","first-page":"22N","volume":"88","author":"JS Clements","year":"1990","unstructured":"Clements JS, Peacock JE (1990) Amphotericin B revisited: reassessment of toxicity. Am J Med 88:22N\u201327N","journal-title":"Am J Med"},{"key":"11_CR5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ki.1991.214","volume":"40","author":"A Llanos","year":"1991","unstructured":"Llanos A, Cieza J, Bernardo J, Echevarria J, Biaggioni I, Sabra R, Branch RA (1991) Effect of salt supplementation on amphotericin B nephrotoxicity. Kidney Int 40:302\u2013308","journal-title":"Kidney Int"},{"key":"11_CR6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0022-3476(88)80653-X","volume":"113","author":"G Koren","year":"1988","unstructured":"Koren G, Lau A, Klein J, Golas C, Bologa-Campeanu M, Soldin S, MacLeod SM, Prober C (1988) Pharmacokinetics and adverse effects of amphotericin B in infants and children. J Pediatr 113:559\u2013563","journal-title":"J Pediatr"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1093\/clinids\/14.Supplement_1.S114","volume":"14","author":"PD Hoeprich","year":"1992","unstructured":"Hoeprich PD (1992) Clinical use of amphotericin B and derivatives: lore, mystique, and fact. Clin Infect Dis 14:S114\u2013S119","journal-title":"Clin Infect Dis"},{"key":"11_CR8","first-page":"28","volume":"16","author":"T Nicholl","year":"1994","unstructured":"Nicholl T, Phillips P, Jewesson PJ (1994) Amphotericin B use in a major acute care hospital. Clin Ther 16:28\u201340","journal-title":"Clin Ther"},{"key":"11_CR9","first-page":"1144","volume-title":"Principles of internal medicine","author":"RJ Anderson","year":"1991","unstructured":"Anderson RJ, Schrier RW (1991) Acute renal failure. In: Wilson JD, Braunwald E, Isselbacher KJ et al (eds) Principles of internal medicine, 12th edn. McGraw Hill, New York, pp 1144\u20131150"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1128\/AAC.42.12.3146","volume":"42","author":"KM Wasan","year":"1998","unstructured":"Wasan KM, Kennedy AL, Cassidy SM et al (1998) The pharmacokinetics, serum lipoprotein and tissue distribution and renal toxicity of amphotericin B (AmpB) and amphotericin B lipid complex (ABLC) in a hypercholesterolemic rabbit model: single dose studies. Antimicrob Agents Chemother 42:3146\u20133152","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/clinids\/24.1.78","volume":"24","author":"KM Wasan","year":"1997","unstructured":"Wasan KM, Conklin JS (1997) Enhanced amphotericin B nephrotoxicity in intensive care patients with elevated levels of low-density lipoprotein cholesterol. Clin Infect Dis 24:78\u201380","journal-title":"Clin Infect Dis"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1128\/AAC.37.2.246","volume":"37","author":"KM Wasan","year":"1993","unstructured":"Wasan KM, Brazeau GA, Keyhani A et al (1993) Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins. Antimicrob Agents Chemother 37:246\u2013250","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/jps.2600830716","volume":"83","author":"KM Wasan","year":"1994","unstructured":"Wasan KM, Morton RE, Rosenblum MG et al (1994) Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: role of lipid transfer protein. J Pharm Sci 83:1006\u20131010","journal-title":"J Pharm Sci"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/AAC.38.2.223","volume":"38","author":"KM Wasan","year":"1994","unstructured":"Wasan KM, Rosenblum MG, Cheung L et al (1994) Influence of lipoprotein-associated amphotericin B on its renal cytotoxicity and antifungal activity. Antimicrob Agents Chemother 38:223\u2013228","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/js970407a","volume":"87","author":"KM Wasan","year":"1998","unstructured":"Wasan KM, Cassidy SM (1998) Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs. J Pharm Sci 87:411\u2013424","journal-title":"J Pharm Sci"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1128\/AAC.45.4.1184-1191.2001","volume":"45","author":"M Ramaswamy","year":"2001","unstructured":"Ramaswamy M, Peteherych KD, Kennedy AL, Wasan KM (2001) Amphotericin B lipid complex or amphotericin B multiple-dose administration to rabbits with elevated plasma cholesterol levels: pharmacokinetics in plasma and blood, plasma lipoprotein levels, distribution in tissues, and renal toxicities. Antimicrob Agents Chemother 45:1184\u20131191","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jac\/43.2.267","volume":"43","author":"AD Luber","year":"1999","unstructured":"Luber AD, Maa L, Lam M et al (1999) Risk factors for amphotericin B-induced nephrotoxicity. J Antimicrob Chemother 43:267\u2013271","journal-title":"J Antimicrob Chemother"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9343(89)80612-6","volume":"87","author":"MA Fisher","year":"1989","unstructured":"Fisher MA, Talbot GH, Maislin G et al (1989) Risk factors for amphotericin B-associated nephrotoxicity. Am J Med 87:547\u2013552","journal-title":"Am J Med"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/319211","volume":"32","author":"DW Bates","year":"2001","unstructured":"Bates DW, Su L, Yu DT, Chertow GM, Seger DL, Gomes DR, Dasbach EJ, Platt R (2001) Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis 32:686\u2013693","journal-title":"Clin Infect Dis"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.7326\/0003-4819-71-6-1089","volume":"71","author":"RP Miller","year":"1969","unstructured":"Miller RP, Bates JH (1969) Amphotericin B toxicity: a follow-up report of 53 patients. Ann Intern Med 71:1089\u20131095","journal-title":"Ann Intern Med"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-005-0011-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-005-0011-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-005-0011-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:06:13Z","timestamp":1559037973000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-005-0011-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,11]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s00280-005-0011-x","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,11]]}}}